SG Americas Securities, LLC
Broker-DealerPosition in NMRA — Neumora Therapeutics, Inc.
CIK 1313360
NEW YORK, NY
Position in NMRA
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$33,497
-$84,779 QoQ
Shares Held
17,178
-74.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in NMRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,497 | 17,178 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $118,276 | 66,076 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $119,204 | 65,497 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $65,287 | 89,069 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $112,395 | 112,395 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $149,661 | 14,119 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $285,085 | 21,581 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $566,276 | 57,607 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $107,551 | 6,308 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||